HeartBeam Strengthens Cardiac Monitoring Technology with Two New U.S. Patents
TL;DR
With new U.S. patents, HeartBeam (NASDAQ: BEAT) strengthens its position in personalized cardiac care, setting itself apart from competitors.
HeartBeam's new patents cover a credit card-sized, cable-free 3D ECG device and a rhythm analysis algorithm for arrhythmia detection, enhancing its innovative cardiac monitoring technology.
HeartBeam's advancements in cardiac care technology promise to revolutionize patient care, enabling real-time monitoring and early detection of cardiac issues outside medical facilities for better health outcomes.
HeartBeam's cable-free 3D ECG device and rhythm analysis algorithm are paving the way for convenient and efficient cardiac monitoring, shaping the future of personalized healthcare.
Found this article helpful?
Share it with your network and spread the knowledge!
Medical technology company HeartBeam Inc. has secured two new U.S. patents that enhance its intellectual property position in cardiac monitoring technology. The patents cover a credit card-sized, cable-free 3D ECG device and an advanced rhythm analysis algorithm designed to improve remote heart health monitoring.
The first patent protects the company's innovative portable ECG device, which enables real-time cardiac monitoring and symptom capture. The second patent safeguards a sophisticated rhythm analysis algorithm capable of identifying arrhythmias through continuous signal input and prompting users to collect 3D ECG data when anomalies are detected.
With these additions, HeartBeam now holds 20 issued patents and has 34 additional patents pending or approved. The expanded patent portfolio strengthens the company's technological platform and supports future product development, including ongoing FDA review of its 12-lead ECG synthesis software.
The new patents represent a significant step toward transforming cardiac care by providing portable, accessible heart monitoring technology. By enabling patients to capture comprehensive cardiac data outside traditional medical settings, HeartBeam aims to improve early detection and management of heart-related conditions.
Curated from InvestorBrandNetwork (IBN)
